Data Foundry

Drug recalls 2022

Acetaminophen 325 mg tablets — Class III drug recall D-1352-2022

Terminated recall by Akron Pharma, Inc., reported 2022-08-24. Failed Tablet/Capsule Specifications: Imprint "AP 325" is missing from the tablet.

Recall numberD-1352-2022
Product typeDrug
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmAkron Pharma, Inc., Fairfield, NJ, United States
Recall initiated2022-08-04
Classified2022-08-17
Reported by FDA2022-08-24
Terminated2023-12-04
Quantity301,382 bottles
NDC71399-8024-01, 71399-8024-02
Lot numbersAKA10621, AKA20621, AKA30621, AKA40621, AKA50621, AKA60621, AKA70621, AKA80621, AKA90621, AKB10621, AKK2021, AKK30421, AKK40421, AKK50421, AKK60421, AKK70421, AKK80421, AKK90421, AKL10421, AKL10521, AKL20421, AKL20521, AKL30521, AKL40521, AKL50521, AKL60521, AKL70521, AKL80521, AKL90521, AKM10521, APR-24, AXA2001, AXA2002, AXA2003, AXA2004, AXA2005, AXA2006, AXA2007, AXA2008, AXA2009 and 8 more

Product

Acetaminophen 325 mg tablets, packaged in a) 100-count bottle (NDC 71399-8024-01); b) 1000-count bottle (NDC 71399-8024-02), Akorn Pharma Manufactured for: Akorn Pharma, Inc., Fairfield, NJ

Reason for recall

Failed Tablet/Capsule Specifications: Imprint "AP 325" is missing from the tablet.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1352-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.